The blockbuster transactions continue in the cannabis space, with Aphria (TSX:APH; OTC:APHQF)’s acquisition of Nuuvera (TSXV:NUU) being the latest, announced on Monday (January 29) for $826 million.
This buyout comes on the heels of fellow LP Aurora Cannabis (TSX:ACB; OTCQB:ACBFF) completing its acquisition of CanniMed Therapeutics (TSX:CMED) for nearly $1.1 billion last week.
According to a joint statement, Aphria will now take command of Nuuvera’s international options, expanding the depth of its international reach. This move comes in the wake of experts predicting the potential for more mergers and acquisition taking place throughout 2018.
“The transaction provides our shareholders with significant value for their investment in Nuuvera and the opportunity to participate in the significant upside of the combined company,” Lorne Abony, CEO of Nuuvera said.

Terms of the buyout from Aphriawhat are inversion deals

Aphria will buy all of Nuuvera’s issued and outstanding common shares, at a price of $8.50 per share. “Nuuvera shareholders will receive $1.00 in cash plus 0.3546 of an Aphria share for each Nuuvera share held which,” the release said.
According to the companies, the buyout will reduce costs from their already established partnership through offtake agreements. On January 11, Aphria and Nuuvera revealed they were in discussions for one of these deals for 60,000 kilograms of cannabis production.
Nuuvera is a smaller producer with intentions on the global cannabis market, counting opportunities in Germany, Israel, and Italy. Its play for the Italian market expanded this month when the company acquired one of the seven licenses to import medical cannabis into the country.


Canadian cannabis market at an international level

With the expected increase in demand for marijuana, Canadian cannabis producers with established business paths are seeking new means of production to meet the interest of in cannabis products, with the recreational legalization of the drug is slated for summer 2018.
On an international level, The international options are opening up for Canadian LPs as well. As companies continue their development plans, markets that are just starting to take off are looking to Canadian producers for guidance and leadership.
Despite the growing excitement for the Canadian cannabis market, both recreational and medical, some companies have started looking beyond that for their overall growth.
According to Bloomberg, Vic Neufeld said in a call with investors, the hope is to have 20 countries under license in a year’s time.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Investor Takeaway

Following the announcement, Nuuvera’s share price rose over 10 percent. On Monday the company closed with a value of $7.73 per share, representing a 10.43 percent increase. This year Nuuvera’s share price has been struggling; at market close on Friday (January 26), its share price had decreased 54.18 percent.
Tim Seymour, a managing partner with Triogem Asset Management tweeted on Monday this deal could open the doors to Aphria having the largest global “footprint.”


During an analyst panel at the Cannabis Lift Expo in Vancouver, the group of experts discussed how merger and acquisition activity in this market could ramp up in 2018. It will be key for investors to keep track of what companies continue their acquisitions.
Don’t forget to follow us @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press releases dated July 21, 2020 and July 31, 2020, the Company proposes to amend the exercise price of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

The Company had initially proposed a lower amended price, but that proposal was not approved by the TSX Venture Exchange (“Exchange“), however, the Exchange indicated that a $0.10 exercise price, may be more acceptable. Accordingly, the proposed amendment remains subject to Exchange approval.

Keep reading... Show less

Issuance of U.S. Patent No. 10,851,077 covering methods for extracting and concentrating cannabinoids using ultrasound-enhanced solvent extraction bolsters World Class’ intellectual patent portfolio

World-Class Extractions Inc. (CSE:PUMP)(FRA:WCF)(OTCQB:WCEXF) (the “Company” or “World-Class”) is pleased to announced the United States Patent and Trademark Office (“USPTO”) has issued U.S. Patent No. 10,851,077 on December 1, 2020 in relation to the Company’s methods for extracting and concentrating cannabinoids and other target compounds from cannabis using ultrasound-enhanced solvent extraction

Keep reading... Show less

Ubican brings well-known brands and is a trusted vendor with an established sales and marketing program

Chemesis International Inc. (CSE:CSI) (OTCQB:CADMF) (FRA:CWAA) (the “Company” or “Chemesis”), announces Ubican Global (“Ubican”) as its primary supplier for its United States VICKI program. Ubican is a trusted supplier of a family of brands, each with multiple types of products. The products include tinctures, digestibles, edibles, pet, beautyskincare, topical, edible, fitness, and smokable products

Keep reading... Show less